Name: da Vinci 5
Brand: Intuitive Surgical

Who's exposed

Deployment status

Shipping, and now the majority of Intuitive's own placements. FDA cleared da Vinci 5 on 14 March 2024 for the specialties already indicated for Xi in adults, excluding cardiac and pediatric; Intuitive ran a deliberately limited launch first, with just 8 systems installed as of 31 March 2024, and moved to full commercial launch in mid-2025. CE mark followed on 2 July 2025 covering adult and pediatric use, and FDA cleared cardiac procedures on 26 January 2026 with non-Force-Feedback instruments only, rolling out to a limited number of US sites through 2026. Placements by period: 362 of 1,526 total da Vinci systems in FY2024, 870 of 1,721 in FY2025, 232 of 431 in Q1 2026 and 246 of 468 in Q2 2026 — roughly 1,710 cumulative, on our own arithmetic from those releases, since Intuitive does not publish a dV5-only installed base. The share crossed 50% in Q4 2025 at 57% and has held above half since, which means da Vinci 5 now outsells Xi, X and SP combined. Total da Vinci installed base was 11,710 systems worldwide at 30 June 2026, up 12% year on year from 10,488. About 3,153,000 da Vinci procedures were performed in 2025, up roughly 18%; Q2 2026 procedure growth ran 15% against full-year guidance of 13.5-15.5%. Intuitive attributed Q4 2025 system utilization growth of 4% primarily to da Vinci 5 adoption in the US. Early ramp evidence: more than 2,500 surgeons performed over 32,000 procedures on da Vinci 5 during 2024.

When this hits the labor market

We have deliberately left the exposed-jobs list empty, as we did for the da Vinci Xi, and the reason is the finding rather than an omission. We went looking for sourced evidence that robotic surgery reduces operating-room headcount and did not find it. What exists is task reallocation — at some hospitals the scrub nurse steps back from the field during console time and the first assistant absorbs those duties — plus a body of work professionalizing the bedside assistant role rather than deleting it. The aggregate signal points the other way: the US Bureau of Labor Statistics projects surgical technologists and assistants to grow about 5% through 2034, with roughly 8,700 openings a year. Intuitive does market da Vinci 5 partly on labor grounds, saying streamlined workflow can help hospitals address staffing challenges, but that claim is footnoted to a simulated human-factors study of 11 surgeons and 22 care-team members, not to measured headcount at any hospital. Treat it as intent, not evidence. The displacement that is actually measurable here runs machine-to-machine: da Vinci 5 is replacing the Xi, with trade-ins rising to 144 in Q2 2026 from 83 a year earlier and about half of US placements now involving one. Over 1-3 years the career consequence for clinicians is a credential gate rather than job loss — the platform most practicing robotic surgeons trained on is being swapped out beneath them, and proficiency on the current generation increasingly decides who gets hired onto a robotic program. Over 3-5 years the variable that sets staffing demand in this category is not robot capability but insurance coverage: Intuitive blamed softer US procedure growth in Q2 2026 on the expiration of ACA subsidies. In surgical robotics, the payer decides the volume.

Intuitive’s real competitor was its own installed base

Two years after clearance, da Vinci 5 has done something none of Intuitive’s rivals has managed: it has taken the majority of Intuitive’s own sales. The company placed 468 systems in the second quarter of 2026, and 246 of them — about 53% — were da Vinci 5. It crossed the halfway mark in Q4 2025 at 57% and has stayed there, which means the fifth generation now outsells the Xi, the X and the SP put together. Roughly 1,710 have shipped since launch, against a worldwide da Vinci installed base of 11,710.

This entry is not here because a robot is coming for a surgeon’s job. It is here because 3.15 million operations a year are moving onto a new machine, and the qualification to stand at that machine is changing with it.

What actually changed

The headline feature is force feedback — the first da Vinci that lets a surgeon feel tissue resistance, cutting force applied to tissue by up to 43% in preclinical testing. It is optional, sold across six instruments, and it comes with a caveat Intuitive publishes itself: the force-feedback needle driver is contraindicated in hysterectomy and myomectomy, because the pivotal trial recorded more unplanned readmissions for vaginal bleeding than the predicate device.

Around that sit more than 150 changes: four times the pixels of the previous generation, an endoscope with a heated tip that stops it fogging, and an insufflator and electrosurgical generator built into the tower instead of stacked beside it. Intuitive says the system carries over 10,000 times the computing power of the Xi — the company’s own figure, footnoted to data on file rather than an independent audit.

Worth keeping in proportion: clearance rested on a 53-patient single-arm study across four specialties. The evidence base has grown since — cardiac clearance came in January 2026, a CE mark in July 2025 — but this was not a machine that arrived with a decade of comparative trials behind it.

Why we care for LostJobs

We left the exposed-jobs list on this entry empty, and that is the finding, not an oversight. We went looking for evidence that robotic surgery cuts operating-room headcount and could not source any. What the literature shows is tasks moving around the table, and the bedside assistant role being formalized rather than eliminated. The Bureau of Labor Statistics projects surgical technologists and assistants to grow about 5% through 2034.

The real substitution here is machine-for-machine. Trade-ins hit 144 in the second quarter, up from 83, and roughly half of US placements now involve one. The Xi is the platform most practicing robotic surgeons learned on, and it is being lifted out from under them.

That is the career signal worth carrying out of this entry, and it generalizes past medicine: the first thing a new generation of machine displaces is usually the previous generation of machine, and the people affected are the ones whose skills were specific to it. Nobody in that operating room is losing a job to da Vinci 5. Some of them are quietly acquiring a recertification problem.

One last constraint deserves naming, because it cuts against the whole thesis of this catalog. What sets the number of robotic operations is not what the robot can do — it is who is covered. Intuitive blamed softer US procedure growth this quarter on ACA subsidies expiring. In this category the payer, not the machine, decides how much work there is.